62 related articles for article (PubMed ID: 21618328)
21. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.
Momtahen AJ; Balci NC; Alkaade S; Akduman EI; Burton FR
Acta Radiol; 2008 Jun; 49(5):490-7. PubMed ID: 18568532
[TBL] [Abstract][Full Text] [Related]
22. Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings.
Mastropasqua M; Kanematsu M; Leonardou P; Braga L; Woosley JT; Semelka RC
Magn Reson Imaging; 2004 Jan; 22(1):15-8. PubMed ID: 14972389
[TBL] [Abstract][Full Text] [Related]
23. Hepatic hemangioma: correlation of enhancement types with diffusion-weighted MR findings and apparent diffusion coefficients.
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Kajita K; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
Eur J Radiol; 2009 May; 70(2):325-30. PubMed ID: 18321673
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity.
Jiang H; Wang Z; Xian J; Li J; Chen Q; Ai L
Acta Radiol; 2012 Feb; 53(1):87-94. PubMed ID: 22184678
[TBL] [Abstract][Full Text] [Related]
25. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
26. Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: the role of laboratory factors.
Chernyak V; Kim J; Rozenblit AM; Mazzoriol F; Ricci Z
J Magn Reson Imaging; 2011 Aug; 34(2):301-9. PubMed ID: 21608069
[TBL] [Abstract][Full Text] [Related]
27. Bone Metastases of Hepatocellular Carcinoma: Appearance on MRI Using a Standard Abdominal Protocol.
Velloni F; Ramalho M; AlObaidy M; Matos AP; Altun E; Semelka RC
AJR Am J Roentgenol; 2016 May; 206(5):1003-12. PubMed ID: 26999036
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of DCE-MRI postprocessing techniques to assess metastatic bone marrow in patients with prostate cancer.
Michoux N; Simoni P; Tombal B; Peeters F; Machiels JP; Lecouvet F
Clin Imaging; 2012; 36(4):308-15. PubMed ID: 22726969
[TBL] [Abstract][Full Text] [Related]
29. Diffusion-weighted imaging and dynamic contrast-enhanced MRI of experimental breast cancer bone metastases--a correlation study with histology.
Merz M; Seyler L; Bretschi M; Semmler W; Bäuerle T
Eur J Radiol; 2015 Apr; 84(4):623-30. PubMed ID: 25641009
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance imaging and image analysis of post - radiation changes of bone marrow in patients with skeletal metastases.
Romanos O; Solomou E; Georgiadis P; Kardamakis D; Siablis D
J BUON; 2013; 18(3):788-94. PubMed ID: 24065500
[TBL] [Abstract][Full Text] [Related]
31. Chemoembolization of hepatic metastases from ocular melanoma: assessment of response with contrast-enhanced and diffusion-weighted MRI.
Buijs M; Vossen JA; Hong K; Georgiades CS; Geschwind JF; Kamel IR
AJR Am J Roentgenol; 2008 Jul; 191(1):285-9. PubMed ID: 18562760
[TBL] [Abstract][Full Text] [Related]
32. Measurements of Hepatic Metastasis on MR Imaging:: Assessment of Interobserver and Intersequence Variability.
Karademir I; Ward E; Peng Y; Wise L; Buckle C; Kunnavakkam R; Oto A
Acad Radiol; 2016 Feb; 23(2):132-43. PubMed ID: 26548855
[TBL] [Abstract][Full Text] [Related]
33. Characterizing hypervascular and hypovascular metastases and normal bone marrow of the spine using dynamic contrast-enhanced MR imaging.
Khadem NR; Karimi S; Peck KK; Yamada Y; Lis E; Lyo J; Bilsky M; Vargas HA; Holodny AI
AJNR Am J Neuroradiol; 2012 Dec; 33(11):2178-85. PubMed ID: 22555585
[TBL] [Abstract][Full Text] [Related]
34. [Characteristic perfusion pattern of osseous giant cell tumor in dynamic contrast-enhanced MRI].
Libicher M; Bernd L; Schenk JP; Mädler U; Grenacher L; Kauffmann GW
Radiologe; 2001 Jul; 41(7):577-82. PubMed ID: 11490778
[TBL] [Abstract][Full Text] [Related]
35. Quantitative bone metastases analysis based on image segmentation.
Erdi YE; Humm JL; Imbriaco M; Yeung H; Larson SM
J Nucl Med; 1997 Sep; 38(9):1401-6. PubMed ID: 9293797
[TBL] [Abstract][Full Text] [Related]
36. MRI differential diagnosis: bone metastases versus bone lesions due to malignant hemopathies.
Bratu AM; Raica VP; Sălcianu IA; Zaharia C; Popa VB; Lupu AR; Ştefănescu V; Dobrea CM; Iana G; Marinescu AN
Rom J Morphol Embryol; 2017; 58(4):1217-1228. PubMed ID: 29556610
[TBL] [Abstract][Full Text] [Related]
37. Multiparametric MR Imaging of Benign and Malignant Bone Lesions.
Tang H; Ahlawat S; Fayad LM
Magn Reson Imaging Clin N Am; 2018 Nov; 26(4):559-569. PubMed ID: 30316467
[TBL] [Abstract][Full Text] [Related]
38. Chemical shift imaging with in-phase and opposed-phase sequences at 3 T: what is the optimal threshold, measurement method, and diagnostic accuracy for characterizing marrow signal abnormalities?
Kumar NM; Ahlawat S; Fayad LM
Skeletal Radiol; 2018 Dec; 47(12):1661-1671. PubMed ID: 29936558
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility Weighted With Quantitative Phase Magnetic Resonance Imaging in Differentiation of Various Stages of Hemorrhage and Calcification in Female Pelvic Pathologies: A Preliminary Study.
Khurana S; Sahoo P; Kapila M; Mittal S; Mahajan M; Saha I; Gupta RK
J Comput Assist Tomogr; 2017; 41(4):586-591. PubMed ID: 28722701
[TBL] [Abstract][Full Text] [Related]
40. [Dynamic features of tumefactive demyelinating lesions in different clinical stages by contrast-enhanced magnetic resonance imaging].
Song DD; Qi XK; Liu JG; Zhao HL; Wang QJ; Diao DW; Wang QQ
Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(43):3513-3518. PubMed ID: 30481901
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
